Carragelose – Respiratory / Eye care / Allergy

Carragelose - The universal blocker

Carragelose is iota-carrageenan, a polymer derived from red seaweed that forms a protective layer on mucosal surfaces.

Mode of action: Carragelose forms a protective layer on mucosal surfaces that prevents viruses and allergens from interacting with the mucosal surface. Furthermore, it adds a moisturizing film that helps to keep the mucosa in the nasal cavity and in the throat resilien

Benefits

  • Clinically validated and patent protected
  • Favourable safety profile – also to be used in children older than one year
  • Unspecific blocker against various external influences, such as viruses or allergens
  • Full-season and versatile product portfolio
  • Carragelose products are certified as medical devices and are on track for MDR transition

Technologies

  • Multidose
  • Spray
  • Lozenges

Therapeutic areas

Viral respiratory diseases

  • Unspecifically blocks respiratory viruses causing the common cold
  • Clinically validated
  • Portfolio of seven marketed nasal and throat products

Eye care

  • Moisturizing eye drops
  • Relief of dry eyes
  • Virus-blocking properties: promising candidate for targeting adenoviral keratoconjunctivitis

Allergy

  • Blocks allergens on the mucosal surface
  • Effective reduction of allergic symptoms in the nose
  • Decongestant effect in combination with sorbitol

 

Partnerships and opportunities

Unither Pharmaceuticals provides its industrial and regulatory expertise for the development, manufacture, and global distribution of Carragelose-based products.
We collaborate with pharmaceutical companies, distributors, and partners seeking to enrich their portfolios with safe, natural, and effective solutions against respiratory viruses.

Additional information